UPDATE Doheny Eye Institute  |  Summer 2017  |  Volume 34, No. 1 doheny.org (continued on page 3) S eventy years can seem like a long stretch or a speck of time, or maybe both, depending on how you view it. At Doheny Eye Institute, the past 70 years skillfully set the stage for 21st century innovations destined to improve eyesight the world over. As many readers already know, our esteemed institute began in 1947 with the launch of its forerunner, the Estelle Doheny Eye Foundation, founded by Mrs. Carrie Estelle Doheny out of a desire to make a positive difference in people’s lives by saving sight. This desire stemmed from Mrs. Doheny’s loss of sight in one eye as she knelt to pray. Unbeknownst to her, she was most likely affected by an advanced stage of glaucoma. Soon afterwards, Mrs. Doheny decided to create a legacy of helping others achieve a life of vision health. Today, Doheny marks its 70th anniversary under the leadership of Executive Director Marissa Goldberg and President and Chief Scientific Officer SriniVas Sadda, MD. We asked Dr. Sadda, who is also an accomplished retinal and macular disease specialist and holder of the Stephen J. Ryan- Arnold and Mabel Beckman Foundation Endowed Presidential Chair, to name a handful of key events, discoveries, or people that helped secure Doheny’s future. We asked for five, but couldn’t resist adding another that he highlighted. “I’d have to say that the first and most pivotal event was Estelle Doheny’s endowment in 1947 to establish the Estelle Doheny Eye Foundation. The facts of her own fading eyesight and her philanthropy were the essence of today’s Doheny Eye Institute.” A second major event, says Dr. Sadda, “... was the recruitment to the eye foundation of Stephen J. Ryan, MD, from his beloved Johns Hopkins School of Medicine in Baltimore, in 1974.“ Even then, in his early 30s, Steve was a pioneering leader who truly understood the power of technology, international collaboration, and big ideas.” Examples include a technology Dr. Ryan developed to study wet age-related macular degeneration (AMD) in laboratory animals, setting the stage for decades of research that’s led to vision-saving therapies; his intellectual horsepower that shaped the clinical, research, and educational framework that defines the Doheny Eye Institute today; and the financial and political capital he built upon which Doheny Eye Institute’s home and reputation are solidly grounded. “A third,” says Dr. Sadda, “would be the 1992 invention of the Baerveldt Glaucoma Implant by Doheny alum, physician-scientist George Baerveldt, MD, for patients with difficult-to-treat glaucoma.” The still-popular implant drains intraocular fluid from a patient’s eye to prevent blinding pressure on the optic nerve. “This was a major medical advance,” says Dr. Sadda, adding that Doheny glaucoma specialists live up to the tradition today with their highly-regarded minimally invasive surgical approaches and their Doheny Eye Institute at 70 Years and Counting KEY SUCCESSES THAT SECURED OUR FUTURE, I ...we asked Dr. Sadda to describe several key events, discoveries, or people that helped secure Doheny’s future. We asked for five, but couldn’t resist adding another that he highlighted. Dr. Srinivas Sadda